This web page is archived for historical purposes and is no longer being updated. Newer data is available on the
STD Data and Statistics page.
Figure 12. Gonorrhea — Rates of Reported Cases by Year, United States, 1941–2014
Figure 13. Gonorrhea — Rates of Reported Cases by Sex, United States, 1994–2014
Figure 14. Gonorrhea — Rates of Reported Cases by Region, United States, 2005–2014
Figure 15. Gonorrhea — Rates of Reported Cases by State, United States and Outlying Areas, 2014
Figure 16. Gonorrhea — Rates of Reported Cases by County, United States, 2014
Figure 17. Gonorrhea — Rates of Reported Cases by Age and Sex, United States, 2014
Figure 18. Gonorrhea — Rates of Reported Cases Among Women Aged 15–44 Years by Age, United States, 2005–2014
Figure 19. Gonorrhea — Rates of Reported Cases Among Men Aged 15–44 Years by Age, United States, 2005–2014
Figure 20. Gonorrhea — Rates of Reported Cases by Race/Ethnicity, United States, 2010–2014
Figure 21. Gonorrhea — Reported Cases by Reporting Source and Sex, United States, 2005–2014
Figure 22. Gonorrhea — Percentage of Reported Cases by Sex and Reporting Source, United States, 2014
Figure 23. Estimated Proportion of MSM, MSW, and Women Among Gonorrhea Cases by Site, STD Surveillance Network (SSuN), 2013
Figure 24. Gonorrhea — Proportion of STD Clinic Patients Testing Positive by Age, Sex, and Sexual Behavior, STD Surveillance Network (SSuN), 2014
Figure 25. Location of Participating Sentinel Sites and Regional Laboratories, Gonoccoccal Isolate Surveillance Project (GISP), United States, 2014
Figure 26. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Ceftriaxone Minimum Inhibitory Concentrations (MICs) (≥0.125 μg/ml), Gonococcal Isolate Surveillance Project (GISP), 2006–2014
Figure 27. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Cefixime Minimum Inhibitory Concentrations (MICs) (≥0.25 μg/ml), Gonococcal Isolate Surveillance Project (GISP), 2006–2014
Figure 28. Neisseria gonorrhoeae — Distribution of Azithromycin Minimum Inhibitory Concentrations (MICs), Gonococcal Isolate Surveillance Project (GISP), 2010–2014
Figure 29. Neisseria gonorrhoeae — Percentage of Isolates with Penicillin, Tetracycline, and/or Ciprofloxacin Resistance, Gonococcal Isolate Surveillance Project (GISP), 2014
Figure 30. Primary Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP), 1988–2014
Next
ShareCompartir